GAYATRI TISSUE & PAPERS LTD. - 512479 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the above, please find enclosed certificate under regulation 74 (5) of SEBI Depositories and Participants Regulations 2018, received from Registrars of our Company - Venture Capital and Corporate Investments Private Limited for the quarter ended 30.06.2021. Gayatri Tissue & Papers Ltd - 512479 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dinesh VemulaDesignation :- Company Secretary and Compliance Officer Gayatri Tissue & Papers Ltd - 512479 - Closure of Trading Window
With reference to the above captioned subject, we hereby inform you that as per SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company''s Code of internal procedures and conduct for regulating, monitoring and reporting of trading by Designated Persons, the trading window for dealing in shares of the company by its designated persons will remain closed with effect from close of working hours on Wednesday 30th June, 2021 for declaration of Un-Audited Financial Results for the Quarter ended 30th June, 2021. The trading window will open 48 hours after the announcement / declaration of the Un-Audited financial results of the Company for the Quarter ended 30th June, 2021. GAYATRI TISSUE & PAPERS LTD. - 512479 - Draft Letter of Offer
CapitalSquare Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Gayatri Tissue & Papers Ltd ("Target Company"). GAYATRI TISSUE & PAPERS LTD. - 512479 - Updates on Open Offer
CapitalSquare Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the Public Shareholders of Gayatri Tissue & Papers Ltd ("Target Company"). Gayatri Tissue & Papers Ltd - 512479 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Company is in receipt of Public Announcement regarding Open Offer being made by the Acquirer M/s. VR Integrated Project Management Private Limited through Capital Square Advisors Private Limited (acting as Manager to the offer). Please find the enclosed Public Announcement received from the Capital Square Advisors Private Limited Gayatri Tissue & Papers Ltd - 512479 - Open Offer
CapitalSquare Advisors Pvt. Ltd. ("Manager to Open Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(1) and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, ("SEBI (SAST) Regulations" or "Regulations") for the attention of the Public Shareholders of Gayatri Tissue & Papers Ltd ("Target Company"). GAYATRI TISSUE & PAPERS LTD. - 512479 - Audited Financial Results For The Quarter And Year Ended 31.03.2021
We wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. 10th of May, 2021 has inter alia approved Audited Financial Results/Statements for the quarter and year ended 31st of March, 2021. Pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a copy of statement of Audited Financial Results and Auditor's Report on the Audited Financial Results for the quarter and year ended 31.03.2021 issued by Statutory Auditors M/s. N G Rao & Associates, Chartered Accountants, enclosed for your records and necessary dissemination. The Board Meeting commenced at 11.30 a.m and concluded at 12.10 p.m GAYATRI TISSUE & PAPERS LTD. - 512479 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company To Be Held On Monday, The 10Th Of May, 2021
GAYATRI TISSUE & PAPERS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2021 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Monday, the 10th of May, 2021 inter alia to consider among other items the following: - To approve the Audited financial results/statements for the quarter and Year ended 31.03.2021. - Any other business with the permission of the chair. It is hereby informed that as per the Company's Code of Conduct for Prevention of Insider Trading pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company is already closed for all designated persons, their immediate relatives and other connected persons, form close of working hours on Wednesday, 31st March, 2021 till the conclusion of 48 hours from the announcement / declaration of the Audited Financial results of the Company for the Fourth quarter and Financial Year ended March 31, 2021. Gayatri Tissue & Papers Ltd - 512479 - Announcement under Regulation 30 (LODR)-Change in Directorate
We wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. 03rd May, 2021 has inter alia approved the appointment of Mr. Nanchraiya Shiva Rama Krishna Pulakanam as Additional Director designated as Non-Executive Director of the Company. Further, in accordance with the circular dated June 20, 2018, issued by the Stock Exchange, he has confirmed that he has not been debarred from holding office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority. Further, there is no inter-se relationship between Mr. Nanchraiya Shiva Rama Krishna Pulakanam and other members of the Board. The details as required under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015; including the brief profile of the above Director is given in Annexure to this letter.